Feifei Chen
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Mesenchymal stem cell research
Papers in
- Epidemiology 12
- Autophagy in Disease and Therapy 5
- Acute Ischemic Stroke Management 4
- Liver Disease Diagnosis and Treatment 3
-
- Epigenetics and DNA Methylation 2
- Signaling Pathways in Disease 2
- Co-authors
- Peisheng Jin (3 shared papers)Qiang Li (3 shared papers)Junnian Zheng (3 shared papers)Yuqing Zheng (1 shared paper)Qiang Li (1 shared paper)Mengxia Yu (5 shared papers)Jing Liu (1 shared paper)Dong‐Sheng Pei (3 shared papers)
- Journals
- Oncotarget (2 papers)PLoS ONE (2 papers)Blood (1 paper)Medicine (1 paper)Biofuels Bioproducts and Biorefining (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Feifei Chen
37 papers receiving 424 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 70
- Genetics 46
- Hematology 49
- Rehabilitation 20
- Molecular Biology 162
Countries citing papers authored by Feifei Chen
This map shows the geographic impact of Feifei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Chen more than expected).
Fields of papers citing papers by Feifei Chen
This network shows the impact of papers produced by Feifei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Chen. The network helps show where Feifei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 53 | |
| 2 | 2013 | 47 | |
| 3 | 2014 | 36 | |
| 4 | 2016 | 36 | |
| 5 | 2018 | 33 | |
| 6 | 2020 | 27 | |
| 7 | 2015 | 26 | |
| 8 | 2014 | 24 | |
| 9 | 2016 | 20 | |
| 10 | 2010 | 16 | |
| 11 | 2011 | 14 | |
| 12 | 2021 | 11 | |
| 13 | 2020 | 10 | |
| 14 | 2020 | 9 | |
| 15 | 2012 | 9 | |
| 16 | 2021 | 5 | |
| 17 | 2022 | 5 | |
| 18 | [Effect and significance of Shenmai injection on value of vascular endothelial active factors of heart valve replacement patients]. | 2009 | 5 |
| 19 | 2024 | 5 | |
| 20 | 2014 | 4 |
About Feifei Chen
Feifei Chen is a scholar working on Epidemiology, Molecular Biology, Oncology, Hematology and Genetics, having authored 43 papers that have together received 426 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Autophagy in Disease and Therapy (5 papers), Acute Ischemic Stroke Management (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Epigenetics and DNA Methylation (2 papers), Signaling Pathways in Disease (2 papers) and Mesenchymal stem cell research (2 papers). The work is most often cited by research in Cancer Research (70 citations), Genetics (46 citations), Hematology (49 citations), Rehabilitation (20 citations) and Molecular Biology (162 citations). Feifei Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Peisheng Jin, Qiang Li, Junnian Zheng, Yuqing Zheng, Qiang Li, Mengxia Yu, Jing Liu, Dong‐Sheng Pei, Yanping Guo and Jie Jin. Their work appears in journals such as Oncotarget, PLoS ONE, Blood, Medicine and Biofuels Bioproducts and Biorefining.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.